Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Assets (2016 - 2025)

Historic Current Assets for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $273.8 million.

  • Ironwood Pharmaceuticals' Current Assets rose 5332.41% to $273.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.8 million, marking a year-over-year increase of 5332.41%. This contributed to the annual value of $182.4 million for FY2024, which is 2182.71% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Current Assets of $273.8 million as of Q3 2025, which was up 5332.41% from $191.8 million recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Current Assets peaked at $866.4 million during Q1 2023, and registered a low of $160.6 million during Q1 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' median Current Assets value was $317.6 million (recorded in 2023), while the average stood at $444.8 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 6572.52% in 2021, then crashed by 7597.18% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Current Assets (Quarter) stood at $745.2 million in 2021, then increased by 4.75% to $780.6 million in 2022, then tumbled by 70.12% to $233.3 million in 2023, then fell by 21.83% to $182.4 million in 2024, then soared by 50.16% to $273.8 million in 2025.
  • Its Current Assets was $273.8 million in Q3 2025, compared to $191.8 million in Q2 2025 and $160.6 million in Q1 2025.